Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
Release Notes Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: FCL012
MIFTS: 50

Facial Paralysis

Categories: Neuronal diseases
Data Licensing
For inquiries, contact:
[email protected]
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Facial Paralysis

About this section

MalaCards integrated aliases for Facial Paralysis:

Name: Facial Paralysis 11 75 43 14 71
Facial Palsy 11 28 5 14
Bell Palsy 71

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)
ICD10: 31


External Ids:

Disease Ontology 11 DOID:13934
MeSH 43 D005158
NCIt 49 C26769
SNOMED-CT 68 90039006
ICD10 31 G51.0
UMLS 71 C0015469 C0376175
Sources

Summaries for Facial Paralysis

About this section

MalaCards based summary: Facial Paralysis, also known as facial palsy, is related to bell's palsy and acoustic neuroma, and has symptoms including tremor, muscle weakness and back pain. An important gene associated with Facial Paralysis is TGFB1 (Transforming Growth Factor Beta 1), and among its related pathways/superpathways are Dendritic Cells Developmental Lineage Pathway and Network map of SARS-CoV-2 signaling pathway. The drugs Acetylcholine and Valaciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, bone and salivary gland, and related phenotypes are renal/urinary system and endocrine/exocrine gland

Wikipedia: 75 Facial nerve paralysis is a common problem that involves the paralysis of any structures innervated by... more...
Sources

Related Diseases for Facial Paralysis

About this section

Diseases related to Facial Paralysis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1041)
# Related Disease Score Top Affiliating Genes
1 bell's palsy 31.8 MTRNR2L5 MARVELD1 LIPN KANTR HOXB1 FKBP4
2 acoustic neuroma 31.2 NF2 FKBP4 CADM1
3 neuroma 31.0 TGFB1 NF2 AQP4
4 poliomyelitis 30.7 CD8A CD4 ALB ACE2
5 parotitis 30.7 CRP CD8A CD4 ALB
6 sarcoidosis 1 30.5 CRP CD8A CD4 ALB ACE
7 uveoparotid fever 30.4 CD4 ACE
8 brain stem infarction 30.4 LIPN CRP
9 multiple cranial nerve palsy 30.4 CRP CD4 ACE
10 abducens palsy 30.3 MOG KANTR CRP AQP4
11 xerophthalmia 30.3 MTRNR2L5 CRP CD8A CD4
12 syphilitic meningitis 30.3 CRP CD4
13 secondary syphilis 30.3 CRP CD8A CD4 ACE
14 intracranial hypertension 30.3 CRP AQP4 ALB ACE
15 nonarteritic anterior ischemic optic neuropathy 30.2 MOG CRP AQP4
16 tolosa-hunt syndrome 30.2 CRP ACE
17 cerebellopontine angle tumor 30.2 NF2 KANTR FKBP4
18 mononeuropathy 30.2 CRP CD4 ALB ACE
19 severe cutaneous adverse reaction 30.2 CRP CD8A CD4
20 viral encephalitis 30.2 MOG CD8A CD4 ACE2
21 chickenpox 30.2 MOG CRP CD8A CD4 AQP4 ALB
22 syphilis 30.2 CRP CD8A CD4 ALB ACE
23 leprosy 3 30.1 CD8A CD4 ALB
24 cat-scratch disease 30.1 CRP CD4 ACE
25 actinomycosis 30.1 CRP CD4 ALB
26 superior mesenteric artery syndrome 30.1 CRP ALB
27 nerve compression syndrome 30.1 LIPN CRP ALB
28 pain agnosia 30.1 LIPN CRP ALB
29 scarlet fever 30.1 CRP CD4 ALB
30 cavernous sinus thrombosis 30.1 CRP CD4 ACE2
31 renal hypertension 30.1 CRP ALB ACE
32 aortic valve insufficiency 30.1 CRP ALB ACE
33 mucormycosis 30.0 CRP CD8A CD4 ACE2
34 common cold 30.0 CRP CD8A CD4 ACE2
35 aseptic meningitis 30.0 MOG CRP CD8A CD4 ALB
36 transient cerebral ischemia 30.0 CRP ALB ACE
37 pericarditis 30.0 CRP ACE2 ACE
38 migraine with or without aura 1 30.0 MTRNR2L5 LIPN CRP AQP4 ALB ACE
39 myelitis 30.0 MOG AQP4 ACE2
40 severe acute respiratory syndrome 30.0 CRP ACE2 ACE
41 glomerulonephritis 30.0 TGFB1 CRP ALB ACE
42 internuclear ophthalmoplegia 30.0 MOG AQP4
43 demyelinating disease 30.0 MOG CD8A CD4 AQP4
44 mediastinitis 30.0 CRP CD4 ALB ACE
45 brachial plexus neuritis 30.0 MOG AQP4
46 stroke, ischemic 30.0 CRP AQP4 ALB ACE2 ACE
47 chronic fatigue syndrome 29.9 CRP CD8A CD4
48 intracranial berry aneurysm 29.9 KANTR CRP ALB
49 exanthem 29.9 CRP CD8A CD4 ALB ACE
50 spondyloarthropathy 1 29.9 CRP CD8A CD4

Comorbidity relations with Facial Paralysis via Phenotypic Disease Network (PDN):


Acute Cystitis Epilepsy, Focal, with Speech Disorder and with or Without Impaired Intellectual Development
Exposure Keratitis Hypertension, Essential
Mechanical Ectropion Paralytic Lagophthalmos
Parotid Gland Cancer Swallowing Disorders
Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Facial Paralysis:



Diseases related to Facial Paralysis
Sources

Symptoms & Phenotypes for Facial Paralysis

About this section

UMLS symptoms related to Facial Paralysis:


tremor; muscle weakness; back pain; ophthalmoplegia; headache; syncope; generalized muscle weakness; hemiplegia; pain; chronic pain; sciatica; seizures; vertigo/dizziness; sleeplessness; oral manifestations; facial paresis; facial palsy, upper motor neuron; facial palsy, lower motor neuron; hemifacial paralysis; flaccid muscle tone

MGI Mouse Phenotypes related to Facial Paralysis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 renal/urinary system MP:0005367 9.86 ACE ACE2 ALB AQP4 CD8A FKBP4
2 endocrine/exocrine gland MP:0005379 9.85 ACE ALB AQP4 CADM1 CD4 CD8A
3 cellular MP:0005384 9.77 ACE ACE2 ALB CADM1 CD4 CD82
4 immune system MP:0005387 9.47 ACE ACE2 ALB AQP4 CADM1 CD4
Sources

Drugs & Therapeutics for Facial Paralysis

About this section

Drugs for Facial Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 63)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
2
Valaciclovir Approved, Investigational Phase 4 124832-27-5, 124832-26-4 60773 135398742
3
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
4
Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
5
Prednisolone Approved, Vet_approved Phase 4 50-24-8 4894 5755
6
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5 1875
7
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 4159 6741
8
Apraclonidine Approved Phase 4 66711-21-5 2216
9
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
10
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7 4897
11
Cortisone Experimental Phase 4 53-06-5 222786
12
abobotulinumtoxinA Phase 4
13 Botulinum Toxins, Type A Phase 4
14 Botulinum Toxins Phase 4
15 Cholinergic Agents Phase 4
16
incobotulinumtoxinA Phase 4
17 Neuroprotective Agents Phase 4
18 Antiemetics Phase 4
19 Gastrointestinal Agents Phase 4
20 Protective Agents Phase 4
21 Antineoplastic Agents, Hormonal Phase 4
22 Hormones Phase 4
23 Hormone Antagonists Phase 4
24 glucocorticoids Phase 4
25 Anti-Inflammatory Agents Phase 4
26
Methylprednisolone Acetate Phase 4 584547
27 Neurotransmitter Agents Phase 4
28 Adrenergic alpha-Agonists Phase 4
29 Adrenergic Agonists Phase 4
30 Adrenergic Agents Phase 4
31 Anti-Arrhythmia Agents Phase 4
32 Sodium Channel Blockers Phase 4
33 Anesthetics, Local Phase 4
34 Anesthetics Phase 4
35 Diuretics, Potassium Sparing Phase 4
36
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2, Phase 3 1177-87-3 3680
37
Dexamethasone Approved, Investigational, Vet_approved Phase 2, Phase 3 50-02-2 3003 5743
38
Phenol Approved, Experimental Phase 2, Phase 3 108-95-2 996
39
Benzocaine Approved, Investigational Phase 2, Phase 3 1994-09-7, 94-09-7 2337
40
Tannic acid Approved Phase 2, Phase 3 1401-55-4 16129878 16129778
41 Pharmaceutical Solutions Phase 2, Phase 3
42
Nimodipine Approved, Investigational Phase 2 66085-59-4 4497
43
Hyaluronic acid Approved, Vet_approved Phase 2 9004-61-9 53477741
44 Antihypertensive Agents Phase 2
45 Vasodilator Agents Phase 2
46 Calcium, Dietary Phase 2
47 calcium channel blockers Phase 2
48 Gelatin Sponge, Absorbable Phase 2
49 Adjuvants, Immunologic Phase 2
50 Viscosupplements Phase 2

Interventional clinical trials:

(show top 50) (show all 74)
# Name Status NCT ID Phase Drugs
1 Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis: Study of Outcomes Before and After Treatment Completed NCT04148872 Phase 4 Chemodenervation (4 months)
2 A Multicentre Placebo-Controlled Evaluation of Prednisolone and/or Valaciclovir for the Treatment of Bell's Palsy Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
3 Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
4 The Facial Nerve Palsy And Cortisone Evaluation (FACE) Study in Children: A Randomized Double-blind, Placebo-controlled, Multicenter Trial Recruiting NCT03781700 Phase 4 Prednisolone;Placebo Oral Tablet
5 Do We Need to Taper Down Steroid Therapy for Bell's Palsy: A Prospective Randomized Controlled Trial Recruiting NCT04406376 Phase 4 Prednisone tablet
6 Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis Not yet recruiting NCT05167760 Phase 4 Apraclonidine
7 Study of the Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
8 Assessment of Corticosteroid Effect in the Prevention of Facial Palsy After Cerebella-pontine Angle Surgery Completed NCT00438087 Phase 3 methylprednisolone
9 Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
10 A Phase 2a, Multicenter, Randomized, Subject and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. Recruiting NCT05293522 Phase 2
11 Intraoperative Application of Nimodipine to the Facial and Cochlear Nerves During Vestibular Schwannoma Resection to Avoid Spasm-related Postoperative Facial Paralysis and Deafness - a Prospective Randomized Pilot Study Recruiting NCT04801953 Phase 2 NiMODipine Injectable Solution
12 Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients With Facial Paralysis Recruiting NCT05012566 Phase 2 Vistabex
13 Mimetic Interfaces - Toispuoleisen Kasvohermohalvauksen Kojeellinen Kuntoutus Terveen Puolen Lihasaktiviteettiohjauksella. Stimulaattorin Prototyypin Testaus terveillä koehenkilöillä ja Kasvohermohalvauspotilailla. Unknown status NCT03496025 Phase 1
14 Validation of a French-language Version of Specific Quality of Life Questionnaires in Patients With Peripheral Facial Palsy Unknown status NCT03581253
15 Comparative Study of Peripheral Facial Paralysis Sequelae Based on the Initial Medical Care of Lyme Disease Among Children Unknown status NCT03981874
16 Ancillary Procedures in Patients of Refractory Facial Palsy Patients Selection and Evaluation of the Outcomes Unknown status NCT04237961
17 Intratympanic Stereoidal Injections for Facial Nerve Palsy Unknown status NCT03371589 Dexamethasone
18 Prednisone Acetate and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, Comparative Effectiveness Research in China Unknown status NCT01201642 Prednisolone
19 Reliability of Multislice Computed Tomography Scan in Cases With Facial Nerve Paralysis Due to Temporal Bone Trauma Unknown status NCT03469427
20 Study of Psychological Factors on the Occurence of Bell's Palsy Unknown status NCT01377766
21 Surgery or Clinical Follow-up in Patients With Bell's Palsy. A Prospective, Parallell, Single Center, Randomized , Open Surgery Clinical Study. Unknown status NCT02179684
22 Photobiomodulation Therapy for Facial Paralysis Over 8 Weeks: An Open-Label Pilot, Non-concurrent Control Study Completed NCT05585333
23 Non-surgical Correction of Eye Lid Paralysis With External Magnet Systems Completed NCT02988856
24 Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis Completed NCT03284125
25 Improvement of Facial Symmetry With Myofunctional Therapy Combined to Botulinum Toxin Injections in Long Standing Facial Paralysis Completed NCT00989209 Botulinum Toxin Type A
26 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226
27 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
28 Function and Form Outcomes in Patients With Facial Paralysis Completed NCT03974763
29 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
30 Photobiomodulation Therapy for Idiopathic Facial Paralysis: Randomized Trial Controlled Completed NCT05585346 Prednisolone Acetate
31 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
32 The Role of MyotonPro in Assessing the Biomechanical Properties of Facial Muscles in Facial Paralysis Patients and Its Role in Monitoring Recovery Following Facial Reanimation Surgery Completed NCT02489162
33 Effect of Laser Acupuncture Treatment on Chronic Facial Paralysis: A Randomized Sham Control, Double Blind Pilot Study Completed NCT03592797
34 Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis Completed NCT04800666 Mecobalamin Tablets
35 Neuro Occlusal Rehabilitation in Patient With Peripheral Facial Paralysis - a Randomized Clinical Trial Completed NCT01327157
36 The Role of Collagen in the Rehabilitation of Peripheral Paralysis of the Facial Nerve Completed NCT04353908
37 Effect of Neural Mobilization in Bells Palsy: A Randomized Controlled Trial Completed NCT04280120
38 Study of Effects of Deqi and Neuropsychological Factors on Acupuncture Effects in Treatment of Bell's Palsy Completed NCT00685789
39 A New Clinical Therapy for Bell's Palsy Completed NCT01686464 prednisone and valacyclovir treatments
40 Antiviral Treatment in Facial Palsy. Randomized Control Trial Completed NCT02328079 Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
41 Production et Perception émotionnelle Chez Les Patients paralysés Faciaux: Marqueurs Respiratoires, Phonatoires et expressivité Faciale. Completed NCT03619720
42 Studying of Acupuncture for Bell's Palsy According to Different Stages Completed NCT00608660
43 Effects of Kabat Technique and Neuromuscular Re-Education in Patients With Bell's Palsy Completed NCT04807491
44 EFFECTIVENESS OF PULSED ULTRASOUND TREATMENT ON PATIENT WITH BELL'S PALSY, A DOUBLE-BLIND, RANDOMÄ°ZED, PLACEBO-CONTROLLED TRIAL Completed NCT04412733
45 Treatment Bell´s Palsy: Prednisone vs Prednisone Valacyclovir Completed NCT00561106 prednisone- valacyclovir;prednisone-placebo
46 Effects of Mirror Therapy Application of Tablet pc on Acute Bell's Palsy. Completed NCT04936152
47 Complications in Parotid Surgery - a Prospective Cohort Study Completed NCT02486393
48 Electro Physiological Responses to Kabat Motor Control Re-education on Bell's Palsy: A Randomized Controlled Study Completed NCT04894513
49 A Pilot Study Evaluating the Effectiveness of Information and Therapy Guides for Improving the Psychosocial Wellbeing of People With Facial Palsy. Completed NCT03943953
50 Stellate Gnaglion Block Versus Conventional Therapey in Refractory Bell's Palsy; A Rondomized Single Blind Clinical Trial Completed NCT05094245

Search NIH Clinical Center for Facial Paralysis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Scopolamine
Scopolamine Hydrobromide

Cochrane evidence based reviews: facial paralysis

Sources

Genetic Tests for Facial Paralysis

About this section

Genetic tests related to Facial Paralysis:

# Genetic test Affiliating Genes
1 Facial Palsy 28
Sources

Anatomical Context for Facial Paralysis

About this section

Organs/tissues related to Facial Paralysis:

MalaCards : Eye, Bone, Salivary Gland, Skin, Brain, Spinal Cord, Tongue
Sources

Publications for Facial Paralysis

About this section

Articles related to Facial Paralysis:

(show top 50) (show all 9549)
# Title Authors PMID Year
1
Posterior reversible encephalopathy syndrome (PRES): Should more attention be paid to the atypical forms? 62
36457790 2023
2
Association Between Clinical Symptoms, Electrodiagnostic Findings, Clinical Outcome, and Prodromal Symptoms in Patients With Bell's Palsy. 62
35109694 2023
3
Sural Nerve Vertical Cross-Face Graft for Lacrimal Gland Neurotization to Improve Tear Secretion in Neurodeprivative Dry Eye. 62
36459583 2023
4
Ruptured bilateral middle cerebral artery aneurysms diagnosed based on cerebral vasospasm-associated ischemic symptoms: A case report. 62
36176966 2022
5
A case of head and neck cutaneous squamous cell carcinoma highlighting aggressive perineural features. 62
36189160 2022
6
Surgical management of tympanojugular paragangliomas using the flexible CO2 laser. 62
35511294 2022
7
Bilateral facial palsy as the first sign of HIV infection. 62
35945381 2022
8
Therapists' perceptions and attitudes in facial palsy rehabilitation therapy: A mixed methods study. 62
33890851 2022
9
Long-term results of upfront, single-session Gamma Knife radiosurgery for large cystic vestibular schwannomas. 62
36471101 2022
10
Asymmetric crying facies in an elderly, when a facial asymmetry is not a facial paralysis but a marker of possible congenital malformations: case report and review of the literature. 62
36456879 2022
11
ELN missense variant in patient with mid-aortic syndrome case report. 62
36460951 2022
12
Physical rehabilitation of central facial palsy: A survey of current multidisciplinary practice. 62
34928754 2022
13
Enhancement of cranial nerves in Lyme neuroborreliosis: incidence and correlation with clinical symptoms and prognosis. 62
35608630 2022
14
Selective Neurectomy for Treatment of Post-Facial Paralysis Synkinesis: A Systematic Review. 62
36155895 2022
15
Incidence and Management of Facial Paralysis After Skull Base Trauma, an Administrative Database Study. 62
36214506 2022
16
Therapeutic strategy for facial paralysis based on the combined application of Si-based agent and methylcobalamin. 62
36438600 2022
17
Effect of the acupuncture within 24 hour after the onset of peripheral facial paralysis. 62
35850903 2022
18
Ectopic thymic carcinoma of the parotid gland. 62
35339333 2022
19
Is There a Role for Cerebral Ultrasonography in Near-Term/Term Neonates Following Assisted Vaginal Delivery? A Prospective, Single-Center Study. 62
32911558 2022
20
Axonal Regeneration Through Autologous Grafts: Does the Axonal Load Influence Regeneration? 62
36037615 2022
21
Coronavirus-associated mucormycosis: different from sinonasal mucormycosis. 62
35791976 2022
22
Superficial versus total parotidectomy for recurrent pleomorphic adenoma in the parotid gland. 62
36067593 2022
23
Comparative analysis of benign and malignant parotid gland tumors: A retrospective study of 992 patients. 62
36473266 2022
24
Aural tuberculosis at the start of the 21st century. Literature review according to SWiM guidelines. Part 2: Treatment. 62
35778340 2022
25
Maxillofacial Skeleton and Facial Anatomy. 62
36244720 2022
26
Hemifacial Spasm Caused by Distal Neurovascular Compression Confirmed by Lateral Spread Response Monitoring. 62
36409872 2022
27
Predicting Depressor Anguli Oris Excision Outcomes Using Local Muscle Block. 62
36378249 2022
28
Does preoperative gamma knife treatment affect the result of microresection of vestibular schwannoma? 62
36316569 2022
29
Dual-Innervated Free Gracilis Muscle Transfer for Facial Reanimation in Children. 62
36279580 2022
30
Treatment, Survival, and Demographics in Temporal Bone Malignancies: A Pooled Data Analysis. 62
36452912 2022
31
Analysis of Risk Factors and Prediction Model for Recurrence of Hemifacial Spasm After Radiofrequency Ablation. 62
36375197 2022
32
Automatic Analysis of Asymmetry in Facial Paralysis Patients Using Landmark-Based Measures. 62
35271372 2022
33
Tri-Vector Gracilis Microneurovascular Free Tissue Transfer with Periocular Component to Achieve a Duchenne Smile in Patients with Facial Paralysis. 62
36265011 2022
34
Commentary on: "Tri-Vector Gracilis Microneurovascular Free Tissue Transfer with Periocular Component to Achieve a Duchenne Smile in Patients with Facial Paralysis" by Byrne et al. 62
36264588 2022
35
Does SARS-CoV2 vaccine exposure trigger acute-onset polyradiculopathy characterized by more common facial paralysis? 62
36059144 2022
36
Pintail Comb Injury as a Rare Cause of Penetrating Temporal Bone Trauma With Facial Paralysis. 62
33172309 2022
37
A rare presentation of a bilateral intracranial parameningeal embryonal rhabdomyosarcoma mimicking vestibular schwannoma in a two-year-old child: a case report. 62
36355193 2022
38
[Clinical application of a self-developed suction-irrigation device in endoscopic ear surgery for attic cholesteatoma]. 62
36404657 2022
39
Malignant external otitis complicated by spinal cord compression: Case report. 62
36389183 2022
40
Fear of falling as a potential complication of Ramsay Hunt syndrome in older adults: a case report. 62
36434527 2022
41
Aural tuberculosis at the start of the 21st century. Literature review according to SWiM guidelines. Part 1: Clinical and diagnostic data. 62
35701295 2022
42
Clinical analysis of acute peripheral facial palsy in older adults. 62
35920320 2022
43
[Evolution in the incidence of infectious diseases in the pediatric ENT area during the COVID-19 pandemic]. 62
36339492 2022
44
Evolution in the incidence of infectious diseases in the pediatric ENT area during the COVID-19 pandemic. 62
36427791 2022
45
Facial involvement in multiple sclerosis. 62
35988397 2022
46
Effect of Filler Therapy on Psychosocial Distress in Facial Paralysis: Patients with Major Asymmetry Derive Greater Benefit. 62
36459105 2022
47
Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series. 62
36398559 2022
48
Acute Bulbar Palsy and Ophtalmoplegia Associated With Anti-GT1a IgG Antibodies. 62
34967823 2022
49
Facial palsy as a manifestation of COVID-19: A systematic review of cases. 62
36320650 2022
50
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report. 62
36263653 2022
Sources

Variations for Facial Paralysis

About this section
Sources

Expression for Facial Paralysis

About this section
Search GEO for disease gene expression data for Facial Paralysis.
Sources

Pathways for Facial Paralysis

About this section

Pathways related to Facial Paralysis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Dendritic Cells Developmental Lineage Pathway 65
11 TGFB1 CD8A CD4
2
Network map of SARS-CoV-2 signaling pathway 74
Show member pathways
 10.81 CRP CD8A CD4 ACE2
Sources

GO Terms for Facial Paralysis

About this section

Biological processes related to Facial Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of systemic arterial blood pressure by renin-angiotensin GO:0003081 9.46 ACE2 ACE
2 response to laminar fluid shear stress GO:0034616 9.43 TGFB1 ACE
3 negative regulation of signaling receptor activity GO:2000272 9.26 MTRNR2L5 MTRNR2L4 ACE2
4 mononuclear cell proliferation GO:0032943 8.8 TGFB1 ACE

Molecular functions related to Facial Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidyl-dipeptidase activity GO:0008241 8.92 ACE2 ACE
Sources

Sources for Facial Paralysis

About this section
2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....